Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.65 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.65 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.65 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.65 |
| ▸ | EDNRA | P25101 | 3/20 | 0.63 |
| ▸ | GBA1 | P04062 | 4/20 | 0.60 |
| ▸ | GLB1 | P16278 | 3/20 | 0.59 |
| ▸ | F2 | P00734 | 1/20 | 0.58 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.58 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.58 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | NSD2 | O96028 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13598031 | 0.92 | HDAC4 (0.60) | HDAC4HDAC10HDAC6HDAC5EDNRA | |
| SCHEMBL4782146 | 0.92 | HDAC4 (0.69) | HDAC4HDAC10HDAC6HDAC5EDNRA | |
| SCHEMBL4126957 | 0.88 | HDAC4 (0.71) | HDAC4HDAC10HDAC6HDAC5EDNRA | |
| SCHEMBL4139459 | 0.88 | HDAC4 (0.75) | HDAC4HDAC10HDAC6HDAC5EDNRA | |
| SCHEMBL19922522 | 0.87 | HDAC4 (0.60) | HDAC4HDAC10HDAC6HDAC5EDNRA | |
| SCHEMBL12686661 | 0.87 | HDAC4 (0.57) | HDAC4HDAC10HDAC6HDAC5EDNRA | |
| SCHEMBL10002025 | 0.87 | HDAC4 (0.62) | HDAC4HDAC10HDAC6HDAC5EDNRA | |
| SCHEMBL4142506 | 0.87 | HDAC4 (0.77) | HDAC4HDAC10HDAC6HDAC5EDNRA | |
| SCHEMBL19603202 | 0.86 | CYP3A4 (0.57) | KDM4ENSD2TSHRHSD17B10 | |
| SCHEMBL12502117 | 0.86 | HDAC4 (0.65) | HDAC4HDAC10HDAC6HDAC5EDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025034780-A1 | STATISTICAL CHARGE-ALTERING RELEASABLE TRANSPORTERS FOR NUCLEIC ACID DELIVERY | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-02-13 | — | — | WO | claimed |
| CN-107880988-B | Environment-friendly forming oil for stainless steel and preparation method thereof | 广州市联诺化工科技有限公司 | 2021-02-09 | — | — | CN | claimed |
| US-12622981-B2 | Immolative cell-penetrating complexes for nucleic acid delivery | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| US-12527882-B2 | Immolative cell-penetrating complexes for nucleic acid delivery | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-01-20 | — | — | US | disclosed |
| EP-4613289-A2 | IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY | The Board of Trustees of the Leland Stanford Junior University (US) | 2025-09-10 | — | — | EP | disclosed |
| EP-3490562-B1 | IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY | UNIV LELAND STANFORD JUNIOR (US) | 2025-09-03 | — | — | EP | disclosed |
| WO-2025072271-A1 | GUANIDINYLATED SERINOL POLYMERIC NUCLEIC ACID TRANSPORTERS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-04-03 | — | — | WO | disclosed |
| WO-2025034780-A1 | STATISTICAL CHARGE-ALTERING RELEASABLE TRANSPORTERS FOR NUCLEIC ACID DELIVERY | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-02-13 | — | — | WO | disclosed |
| US-12215341-B2 | Hybrid immolative cell-penetrating complexes for nucleic acid delivery | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-02-04 | — | — | US | disclosed |
| US-20240277870-A1 | IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2024-08-22 | — | — | US | disclosed |
| CN-115252807-A | Disaggregated cell-penetrating complexes for nucleic acid delivery | 利兰斯坦福初级大学董事会 | 2022-11-01 | — | — | CN | disclosed |
| US-7939621-B2 | Oligocarbonate molecular transporters | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-05-10 | — | — | US | disclosed |
| US-20110045100-A1 | Antimalarial Quinolines and Methods of Use Thereof | GEORGETOWN UNIVERSITY (US) | 2011-02-24 | — | — | US | disclosed |
| US-20110045100-A1 | Antimalarial Quinolines and Methods of Use Thereof | GEORGETOWN UNIVERSITY (US) | 2011-02-24 | — | — | US | disclosed |
| US-20100280219-A1 | OLIGOCARBONATE MOLECULAR TRANSPORTERS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2010-11-04 | — | — | US | disclosed |
| US-20100280219-A1 | OLIGOCARBONATE MOLECULAR TRANSPORTERS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2010-11-04 | — | — | US | disclosed |
| US-20100280219-A1 | OLIGOCARBONATE MOLECULAR TRANSPORTERS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2010-11-04 | — | — | US | disclosed |
| WO-2009148659-A2 | ANTIMALARIAL QUINOLINES AND METHODS OF USE THEREOF | GEORGETOWN UNIVERSITY (US) | 2009-12-10 | — | — | WO | disclosed |
| WO-2009144344-A2 | COMPOUND FOR LABELLING BIOMOLECULES BASED ON VINYLSULPHONE, PREPARATION AND USES | UNIVERSIDAD DE GRANADA (ES) | 2009-12-03 | — | — | WO | disclosed |
| US-5512486-A | Single step signal group-imidazole labeling of organic phosphate groups under aqueous conditions | NORTHEASTERN UNIVERSITY (US) | 1996-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622981-B2 | Immolative cell-penetrating complexes for nucleic acid delivery | NPC1L1, NPC1, SCP2 | HDAC4 2147/4885HDAC10 1492/4885HDAC6 2707/4885 |
| US-20240277870-A1 | IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY | RNASE1, IPO9, DNASE1L3 | HDAC4 2992/4885HDAC10 2962/4885HDAC6 2410/4885 |
| US-20110045100-A1 | Antimalarial Quinolines and Methods of Use Thereof | NQO2, QTRT1, QTRT2 | HDAC4 3044/4885HDAC10 2714/4885HDAC6 1030/4885 |
| US-20100280219-A1 | OLIGOCARBONATE MOLECULAR TRANSPORTERS | SLC10A6, SLCO2B1, SLCO4C1 | HDAC4 2793/4885HDAC10 604/4885HDAC6 3336/4885 |
| US-12527882-B2 | Immolative cell-penetrating complexes for nucleic acid delivery | CCRL2, HAVCR2, CCR3 | HDAC4 1782/4885HDAC10 3391/4885HDAC6 2498/4885 |
| US-12215341-B2 | Hybrid immolative cell-penetrating complexes for nucleic acid delivery | RNASE1, DNASE1L3, IPO9 | HDAC4 2538/4885HDAC10 2620/4885HDAC6 2178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.